For IOL brands
Make Your Product Value Survive the Last Mile
A strong clinical claim does not automatically become patient-perceived value. I help IOL brands understand where adoption breaks, redesign the decision pathway and test a scalable model in real clinics.
The complete patient journey
What First Mile and Last Mile Actually Mean
The product moves through a clinical and commercial value chain. The patient moves through a decision journey. Adoption depends on whether those two systems meet.
Before the clinic
First Mile
Search, AI answers, brand and clinic content, patient stories and referral conversations shape what the patient expects and trusts.
The product is simplified, overpromised or never becomes personally relevant.
Where value changes hands
Clinic Handoff
The brand narrative passes through local marketing, the clinic, staff and the surgeon — each adding interpretation and operational constraints.
Clinical differentiation arrives as a specification, not as usable decision support.
Inside the consultation
Last Mile
The patient must connect a clinically relevant option with their own visual priorities, understand the trade-offs and make a confident shared decision.
Fear, overload or an inconsistent offer sends the patient to the default.
Where value gets lost
The Gap Between Clinical and Perceived
Three recurring reasons why a differentiated technology quietly becomes just another option at the point of decision.
Clinical claims stay clinical
Differentiation lives in optics, outcomes and technical language — but not in terms the patient can connect with real life.
Translation is left to the clinic
The surgeon or counsellor has to invent the bridge from technology to value, differently in every clinic and every consultation.
Adoption is treated as a sales problem
More promotion reaches the same unmanaged decision environment, while the real barriers remain invisible.
The strategic engagement
From Market Diagnosis to a Scalable Adoption Model
This is not an advertising assignment or a set of isolated patient-language assets. It is a senior market or regional program built around a defined product and adoption challenge.
Market Adoption Evaluation
Build an evidence-based view of how premium decisions are actually made in the target market — where the product enters the journey, where value is lost and how clinics experience the current support model.
- Market and pathway diagnosis
- Clinic and stakeholder insight
- Priority adoption barriers
Patient-Value Architecture
Translate clinical differentiation into patient-relevant value, honest trade-off language and a communication structure that commercial teams and clinics can use without overclaiming.
- Patient-value narrative
- Communication and decision architecture
- Clinic-facing implementation tools
Clinic Pilot and Scale-Up
Apply the model in selected clinics, align the field and clinic teams, measure early indicators and turn what works into a practical market-level growth playbook.
- Pilot pathway and enablement
- Measurement and learning loop
- Scale-up playbook
The starting point can vary, but the work is scoped around an adoption outcome and a market learning agenda — not around the production of individual marketing deliverables.
Invited keynote · Bausch + Lomb European Premium Transformation meeting · Budapest, 2026
Why this perspective is different
Both Sides of the Adoption Problem
The work combines industry operating experience with direct evidence of how patients interpret premium technology — two perspectives that are usually separated.
In ophthalmology since 1996, across technology, distribution, application and market development
Hands-on work with private clinics and the operational reality of premium pathways
Approximately 9,000 unique patient responses from IOL decision research
20M+ YouTube views built by translating clinical complexity into patient language
Engagement model
Project-Based, Not Retainer-First
The first engagement is built around a specific market, product and adoption challenge. Ongoing advisory support makes sense after the model, responsibilities and implementation agenda are clear.
Start the conversation
If the Last Mile Matters to Your Product, We Should Talk.
Tell me about the product, market and adoption challenge you need to solve.